← FDA Drug Approvals (Drugs@FDA)
HORIZANT
NDA · New Drug Application · Sponsor: AZURITY · Approved 2011-04-06
Drug application
- FDA Application #
NDA022399- Application type
- New Drug Application
- Brand name
- HORIZANT
- Generic name
- GABAPENTIN ENACARBIL
- Active ingredients
- GABAPENTIN ENACARBIL
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- First approval
- 2011-04-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown